Samenvatting
De prevalentie van diabetes mellitus bedraagt 2-4% in welvarende westerse landen en 1-2% in ontwikkelingslanden. Bij diabetes worden twee hoofdtypen onderscheiden: diabetes mellitus type 1 en type 2.
This is a preview of subscription content, log in via an institution.
Literatuur
Koolhydraatstofwisseling
Devendra D (2004) Type-1-diabetes: recent developments. BMJ 328:750–754
De Fronzo RA et al. International textbook of diabetes mellitus. 3e druk. Chicester Wiley, 2004
Frank RN. Diabetic retinopathy. N Eng J Med 2004;350:48–58
Haffner SM. Mortality from coronary heart disease in subjects with type-2-diabetes and in nondiabetic subjects with and without prior myocardial infarction. N Eng J Med 1998;339:229–234
King H et al. Global burden of diabetes 1995-2025: prevalence, numerical estima-tes and projections. Diabetes Care 1998;21:1414–1431
Pickup J, Williams G. Textbook of diabetes. 3e druk., Oxford Blackwell 2002
Pickup J, Williams G. Handbook of diabetes. 3e druk., Oxford Blackwell 2004
Remuzzi G et al. Nephropathy in patients with type-2-diabetes. N Eng J Med 2002;346:1145–1151
Ritz E, Orth SR. Nephropathy in patients with type-2-diabetes mellitus. N Eng J Med 1999;341:1127–1133
Vegt F de, et al. Relation of impaired fasting and post-load glucose with incident type 2 diabetes in a Dutch population: the Hoorn Study. JAMA 2001;285:2109–2113
Vetstofwisseling:
Carlson LA et al. Current Hyperlipidaemia. 2e druk. London Science Ltd.,2001
Durrington P, Sniderman A. Hyperlipidaemia. Oxford: Health Press Ltd., 2000
Gotto AM et al. The ILIB Lipid Handbook for Clinical Practice. 3e druk. New York: International Lipid Information Bureau, 2003
Grundy SM et al. Definition of Metabolic Syndrome. Report of the National Heart, Lung, and Blood Institute / American Heart Association Conference on Scien-tific Issues Related to Definition. Circulation 2004;109:433–438
Manson JE et al. Women's health initiative investigators. Estrogen plus progestin and the risk of coronary heart disease. New Eng J Med 2003;349:523–534
McLaughin T et al. Use of metabolic markers to identify overweight individuals who are insulin resistant. Ann Int Med 2003;139:802–809
Reaven GM. Importance of identifying the overweight patient who will benefit the most by losing weight. Ann Int Med 2003;138:420–423
Editor information
Rights and permissions
Copyright information
© 2005 Bohn Stafleu van Loghum, Houten
About this chapter
Cite this chapter
Reitsma, W., Elte, J. (2005). Hoofdstuk 7 Afwijkingen van de koolhydraat- en vetstofwisseling. In: Reitsma, W., Elte, J., Overbosch, D. (eds) Differentiële diagnostiek in de interne geneeskunde. Bohn Stafleu van Loghum, Houten. https://doi.org/10.1007/978-90-313-9279-7_7
Download citation
DOI: https://doi.org/10.1007/978-90-313-9279-7_7
Publisher Name: Bohn Stafleu van Loghum, Houten
Print ISBN: 978-90-313-4282-2
Online ISBN: 978-90-313-9279-7
eBook Packages: Dutch language eBook collection